Meridian Investment Counsel’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
13,206
+470
| +4% | +$39K | 0.3% | 94 |
|
|
2025
Q1 | $1.03M | Buy |
12,736
+29
| +0.2% | +$2.35K | 0.3% | 95 |
|
|
2024
Q4 | $1.14M | Sell |
12,707
-1,070
| -8% | -$96.4K | 0.34% | 81 |
|
|
2024
Q3 | $1.36M | Sell |
13,777
-1,760
| -11% | -$174K | 0.41% | 74 |
|
|
2024
Q2 | $1.44M | Buy |
15,537
+1,275
| +9% | +$118K | 0.46% | 69 |
|
|
2024
Q1 | $1.35M | Buy |
14,262
+945
| +7% | +$89.7K | 0.45% | 68 |
|
|
2023
Q4 | $1.19M | Sell |
13,317
-470
| -3% | -$42K | 0.41% | 71 |
|
|
2023
Q3 | $1.01M | Sell |
13,787
-355
| -3% | -$25.9K | 0.38% | 76 |
|
|
2023
Q2 | $1.18M | Sell |
14,142
-100
| -0.7% | -$8.32K | 0.42% | 66 |
|
|
2023
Q1 | $1.09M | Sell |
14,242
-200
| -1% | -$15.2K | 0.41% | 68 |
|
|
2022
Q4 | $1.2M | Sell |
14,442
-391
| -3% | -$32.5K | 0.48% | 63 |
|
|
2022
Q3 | $1.18M | Sell |
14,833
-79
| -0.5% | -$6.27K | 0.52% | 57 |
|
|
2022
Q2 | $1.11M | Buy |
14,912
+257
| +2% | +$19.1K | 0.46% | 67 |
|
|
2022
Q1 | $1.32M | Buy |
14,655
+380
| +3% | +$34.1K | 0.46% | 66 |
|
|
2021
Q4 | $1.6M | Buy |
14,275
+237
| +2% | +$26.5K | 0.53% | 51 |
|
|
2021
Q3 | $1.77M | Buy |
14,038
+1,884
| +16% | +$237K | 0.64% | 41 |
|
|
2021
Q2 | $1.65M | Buy |
12,154
+3,264
| +37% | +$442K | 0.58% | 47 |
|
|
2021
Q1 | $1.21M | Buy |
8,890
+130
| +1% | +$17.6K | 0.47% | 60 |
|
|
2020
Q4 | $1.23M | Buy |
8,760
+420
| +5% | +$59.1K | 0.52% | 52 |
|
|
2020
Q3 | $929K | Hold |
8,340
| – | – | 0.45% | 59 |
|
|
2020
Q2 | $934K | Buy |
8,340
+165
| +2% | +$18.5K | 0.48% | 58 |
|
|
2020
Q1 | $633K | Buy |
8,175
+5,345
| +189% | +$414K | 0.41% | 70 |
|
|
2019
Q4 | $269K | Buy |
+2,830
| New | +$269K | 0.13% | 148 |
|
|
2019
Q3 | – | Sell |
-2,305
| Closed | -$202K | – | 182 |
|
|
2019
Q2 | $202K | Buy |
+2,305
| New | +$202K | 0.11% | 166 |
|